Has Eugene Wong, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,140 in general payments to Eugene Wong, MD across 141 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eugene Wong, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eugene Wong, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eugene Wong, MD

Hospitalist · New York, NYNPI 1942308580

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,429 of the $9,140 with a category attached, or 70.3%. It is spread thinly across 28 manufacturers, the largest accounting for just 18.0%. Among hospitalist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,140in general payments, 2019–2025

Across 141 payments — averaging $64.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$2K
Johnson & Johnson$1K
Maquet Cardiopulmonary GmbH$800
AbbVie$703
BD$672
C. R. Bard, Inc. & Subsidiaries$625
plus $3K from 22 others

What the payments were for

Consulting fees$2,35226%
Speaking & faculty fees$3524%
Food & beverage$6,42970%
Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	24	$1,644
Johnson & Johnson	37	$1,397
Maquet Cardiopulmonary GmbH	1	$800
AbbVie	20	$703
BD	4	$672
C. R. Bard, Inc. & Subsidiaries	2	$625
Boehringer Ingelheim	12	$569
Inari Medical, Inc.	3	$447
Bard Peripheral Vascular, Inc.	1	$300
Pfizer	6	$271
Incyte Corporation	2	$252
E.r. Squibb & Sons, L.L.C.	4	$185
Cepheid	1	$170
Merck	3	$164
Abbott	2	$157
GE HealthCare	1	$137
Teva Pharmaceuticals USA, Inc.	1	$125
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$125
Paratek Pharmaceuticals, Inc.	3	$68
Irhythm Technologies, Inc.	2	$57
Novartis	2	$49
Harmony Biosciences LLC	1	$48
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$44
Bristol Myers Squibb	2	$38
Scpharmaceuticals Inc.	1	$25
Kiniksa Pharmaceuticals International, PLC	1	$25
Convatec Inc.	1	$24
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,140 in reported general payments places this provider in the 95th percentile of 1,860 hospitalist providers in New York.

See all hospitalist providers in New York →

Medicare billing

Part B allowed, 2024

$84,465

Medicare patients

362

Services billed

575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hospitalist in New York

Yair SapersteinNew York$43K
Timothy TiutanNew York$42K
Natasha VartakNew York$35K
Sunil BhattNew York$25K
Domenico AcciliNew York$21K
Peter TingNew York$17K
Amihai RottenstreichNew York$16K
Matthew McCarthyNew York$12K
John ChelicoNew York$11K
Richard LinNew York$11K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →